| Michael L. Laccheo, M.d., P.a. | |
|
1119 Sw Gage Blvd Topeka KS 66604-1999 | |
| (785) 271-6000 | |
| (785) 271-6321 |
| Full Name | Michael L. Laccheo, M.d., P.a. |
|---|---|
| Speciality | Family Medicine |
| Location | 1119 Sw Gage Blvd, Topeka, Kansas |
| Authorized Official Name and Position | Michael Lewis Laccheo (PRESIDENT) |
| Authorized Official Contact | 7852716000 |
| Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
| Mailing Address | Practice Location Address |
|---|---|
| Michael L. Laccheo, M.d., P.a. 1119 Sw Gage Blvd Topeka KS 66604-1999 Ph: (785) 271-6000 | Michael L. Laccheo, M.d., P.a. 1119 Sw Gage Blvd Topeka KS 66604-1999 Ph: (785) 271-6000 |
| NPI Number | 1114039823 |
|---|---|
| Provider Enumeration Date | 08/31/2006 |
| Last Update Date | 08/22/2020 |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114039823 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 19586 (Kansas) | Primary |
News Archive
Integrated Technologies Ltd has successfully achieved accreditation of ITL Virginia Inc., its wholly owned subsidiary in the United States, to ISO 13485.
Results of the GeparQuinto study, randomized Phase III efficacy data on the use of bevacizumab plus chemotherapy to treat women with early breast cancer will be presented at the 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium.
Odyssey Thera, Inc. announced today that the United States Patent and Trademark Office granted U.S. Patent No. 7,935,493, entitled "Protein fragment complementation assays for high-throughput and high-content screening."
PBS NewsHour on Monday profiled five projects to improve maternal and child health that are competing for a share of $14 million in research grants through the Saving Lives at Birth challenge.
Repligen Corporation announced today that the Office of Orphan Products Development of the Food and Drug Administration has granted orphan drug designation to RG2833, a selective histone deacetylase 3 inhibitor for the treatment of Friedreich's ataxia. Orphan drug designation qualifies Repligen to receive seven years of marketing exclusivity in the United States if the company is the first to obtain marketing approval for RG2833 for the treatment of Friedreich's ataxia.
› Verified 6 days ago
Topeka Infectious Disease & Endocrinology Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 631 Sw Horne St, Suite 420, Topeka, KS 66606 Phone: 785-234-8405 Fax: 785-235-1702 | |
Promedt Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1125 Sw Gage Blvd, Suite C, Topeka, KS 66604 Phone: 785-783-3706 | |
Marian Dental Clinic - Scl Health Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 3164 Se 6th Ave, Topeka, KS 66607 Phone: 785-233-2800 Fax: 785-233-5116 | |
Chester R Davis Md Pa Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1125 Sw Gage Blvd, Ste C, Topeka, KS 66604 Phone: 785-232-7324 Fax: 785-354-7155 | |
Topeka Consulting Physicians Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 3520 Sw Alameda Dr, Topeka, KS 66614 Phone: 785-438-0073 | |
Minor Med Pa Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1119 Sw Gage Blvd, Topeka, KS 66604 Phone: 785-272-4000 Fax: 785-272-0894 | |
Department Of Veteran Affairs Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 2200 Sw Gage Blvd, Attn: Hud-vash, Topeka, KS 66622 Phone: 785-350-3111 |